Monasterium Laboratory
- Company typePrivate
- Founded2015
- HeadquartersMünster, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Monasterium Laboratory does
Monasterium Laboratory is a German-based preclinical and clinical contract research organization (CRO) operating as the Monasterium-branded German subsidiary of QIMA Life Sciences, a platform consolidated under the UK parent QIMA LTD alongside QIMA Bioalternatives, QIMA Newtone, and QIMA Skinpharma. Founded in 2015 in Münster and led by founder and CEO Ralf Paus, it provides B2B research and testing services to cosmetics/personal care and pharmaceutical/biotech clients, spanning in silico screening, in vitro and ex vivo biological models (including 3D reconstructed skin, ex vivo hair follicle organ culture, and fresh whole blood assays), analytical chemistry and bioanalysis, preclinical in vivo rodent studies, and clinical sampling, imaging, and trial support. The group operates more than 10,000 m² of laboratory space across five R&D sites in Germany, France, and Brazil, with a referenced track record of more than 300 co-authored scientific publications, and markets proprietary digital imaging tools (DigiCam, SkinCam Pro, SpectraCam, Colorface) and an AI-based vitiligo assessment product (Vitil-IA).
The business model is project-based professional services revenue: clients engage via direct enterprise sales channels ('I have a Project' / Contact Us) and receive quote-based proposals for tailored preclinical or clinical research programs rather than standardized product pricing. Customer segments are split between Cosmetics & Personal Care (skincare, haircare, nutraceutical claim substantiation) and Pharma & Biotech (dermatology, immune-inflammation, oncology, neurobiology, and veterinary medicine), with indication coverage extending from atopic dermatitis, vitiligo, psoriasis, alopecia, and wound healing to oncology, neurocosmetics, and canine dermatology. Go-to-market relies on scientific content marketing — peer-reviewed publications, webinars, conference participation at SID, EADV, AAD, ESDR, IFSCC, and others — and on the credibility of a nearly three-decade domain track record to win enterprise R&D engagements.
Monasterium Laboratory firmographics
Firmographics- Name
- Monasterium Laboratory
- Legal name
- QIMA LTD
- Website
- https://monasteriumlab.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Monasterium Laboratory industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Professional, Scientific, and Technical Services (54)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where Monasterium Laboratory is headquartered
LocationHeadquarters
- HQ city
- Münster
- HQ country
- Germany
- HQ region
- Europe
Offices6 records
Markets served
Monasterium Laboratory business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Research Services: B2B contract research services for cosmetics and pharmaceutical companies, providing preclinical testing, clinical evaluation, and analytical services on a project basis. Services range from in vitro screening to clinical trials.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Monasterium Laboratory product offering
Product offeringCore offering
Monasterium Laboratory operates as a preclinical contract research organization (CRO) under the QIMA Life Sciences brand, delivering in silico, in vitro, ex vivo, and in vivo research and testing services for the cosmetics, personal care, and pharmaceutical industries. The portfolio spans efficacy and safety testing, analytical chemistry and bioanalysis, clinical imaging, clinical trial support, and specialized dermatology, immunology, oncology, and neurobiology models. Service delivery is anchored by the Münster, Germany facility and is complemented by additional R&D sites within the QIMA Life Sciences network.
Product overview
QIMA Life Sciences (parent company of Monasterium Laboratory in Germany) operates as a world-leading preclinical CRO offering end-to-end research and testing services from in vitro to clinical stages. The portfolio spans Discovery & Preclinical services (in silico screening, in vitro/ex vivo models, analytical chemistry, in vivo rodent models), Clinical Research services (bioanalysis, clinical sampling, imaging, trials), Cosmetics & Personal Care testing (skincare, haircare, nutraceuticals), and Pharma & Biotech services (dermatology, immunology, oncology, neurobiology, veterinary medicine). Key products include proprietary AI-powered imaging systems like Vitil-IA for automated vitiligo assessment, clinical imaging platforms (DigiCam, SkinCam Pro, SpectraCam), and specialized ex vivo models for hair follicle, skin, and immune research. Services are delivered across five R&D sites with over 10,000 m² of laboratories.
Differentiator
Problem solved
Functional benefit
Products and services
- In Silico Services Computational chemistry and virtual screening services for drug discovery and cosmetic ingredient evaluation, supporting cosmetics and pharmaceutical R&D teams.
- In Vitro & Ex Vivo Models Comprehensive in vitro and ex vivo biological models including 3D reconstructed skin models, cell-based assays, and tissue explants for preclinical research in cosmetics and dermatology.
- Assays on Fresh Whole Blood Fresh whole blood assay services for evaluating immunological and inflammatory responses, supporting preclinical pharmacology and immunology studies.
- Analytical Chemistry and Bioanalysis Analytical and bioanalytical services including chromatography, mass spectrometry, and bioanalysis of clinical samples for cosmetics and pharmaceutical clients.
- Preclinical In Vivo Rodent Models In vivo preclinical testing services using rodent models for drug efficacy and safety assessment in dermatology and related therapeutic areas.
- Clinical Trials Clinical research services including clinical sampling, imaging, and trial management for dermatology and cosmetics applications.
- Clinical Imaging (Newtone) Digital clinical imaging solutions including DigiCam, SkinCam Pro, SpectraCam, and Colorface for objective product performance assessment in skin and hair research.
- Skin Longevity Testing Assays to study hallmarks of skin aging including mitochondrial dysfunction and telomere attrition, used for cosmetic claim substantiation in longevity and anti-aging products.
- Skin Barrier & Hydration Testing Comprehensive evaluation of skin barrier function and hydration for cosmetic and dermatology product testing and claim substantiation.
- Skin Pigmentation Testing Testing services for skin pigmentation and melanogenesis responses to cosmetic ingredients, supporting pigmentation-related product claims.
- Hair Growth Testing Ex vivo human hair follicle organ culture models and assays for evaluating hair growth promotion and hair loss treatments for cosmetic and pharmaceutical clients.
- Dermatology Drug Discovery Preclinical to clinical research services for dermatological conditions including atopic dermatitis, vitiligo, psoriasis, alopecia, wound healing, and skin cancer indications.
- Immune-Inflammation Services Immunology and inflammation research services including immune response testing and macrophage models for pharma and biotech clients.
- Oncology Research Cancer research models including tumor models, immuno-oncology assays, and bi-specific antibody evaluation for oncology drug development.
- Veterinary Medicine Models In vitro canine models including 2D and 3D models for veterinary dermatology and pharmaceutical testing in animal health applications.
- Vitil-IA AI-powered automated imaging system for quantification of facial vitiligo using standardized UV imaging and machine learning algorithms.
- SQINsight Sensory and neuroscience-based evaluation platform for neurocosmetics supporting sensory comfort and perceived well-being claims.
Quantifiable outcome
- 300+ published scientific works demonstrating scientific credibility and collaborative research capabilities
Companies that use Monasterium Laboratory
Customer profileSegments2 records
Ideal customer profiles2 records
Monasterium Laboratory technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
Monasterium Laboratory partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Monasterium Laboratory competitors and assessment
Company assessmentDirect peers
- SGS SA: Global testing, inspection, and certification company operating dedicated cosmetics and personal-care testing labs in Europe. Directly comparable service offering and customer base to Monasterium's Cosmetics & Personal Care segment.
- Eurofins Scientific: Eurofins operates extensive cosmetics and dermatology product testing laboratories across Europe, offering claim substantiation, safety, and efficacy testing. Directly competes with Monasterium on the cosmetics/personal-care claim-substantiation workflow.
- Inotiv: Preclinical CRO with specialty in vivo models, safety assessment, and research models for pharma and consumer-products clients. Directly comparable in preclinical in vivo rodent and specialty model capabilities.
- Intertek Group: Global TIC provider with established cosmetics testing and clinical-research services, including analytical chemistry and claim substantiation. Competes for the same cosmetics and dermatology client engagements.
Emerging players
- Sinclair Pharma: Dermatology-focused pharma company developing and commercializing skin therapeutics. Operates adjacent in the dermatology value chain and represents a potential pharma partner/customer for Monasterium's preclinical services.
- Bionova Scientific: Specialty analytical CRO providing GMP testing, bioanalysis, and characterization services for biologics. Comparable on the analytical chemistry/bioanalysis capability but focused on biologics rather than cosmetics.
- Crown Bioscience: Preclinical CRO with specialty in vivo and in vitro oncology and inflammation models, increasingly expanding into dermatology and immuno-inflammation. Overlaps with Monasterium's oncology and immune-inflammation service lines.
Broad incumbents
- IQVIA: World's largest clinical CRO offering full Phase I-IV services plus R&D Solutions for preclinical work. Overlaps with Monasterium's clinical trials offering and represents the dominant scaled competitor for integrated dermatology programs.
- ICON plc: Major global CRO providing clinical research, laboratory, and consulting services to pharma and biotech, including dermatology programs. Comparable in clinical CRO delivery model though broader in therapeutic scope.
- Charles River Laboratories: Global preclinical CRO with a Discovery & Safety Assessment segment that includes in vivo rodent models, in vitro services, and dermatology/cosmetics testing. Directly comparable in preclinical CRO scope but at far larger scale and broader therapeutic coverage.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Monasterium Laboratory social profiles
Digital presenceMonasterium Laboratory financial estimates
Financial estimateRevenue estimate
Valuation estimate
Monasterium Laboratory leadership team
Management profileNumber of profiles
Profiles1 record
Monasterium Laboratory subsidiaries and ownership
Company hierarchySubsidiaries5 records
Monasterium Laboratory funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Monasterium Laboratory M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Monasterium Laboratory
What does Monasterium Laboratory do?
Monasterium Laboratory operates as a preclinical contract research organization (CRO) under the QIMA Life Sciences brand, delivering in silico, in vitro, ex vivo, and in vivo research and testing services for the cosmetics, personal care, and pharmaceutical industries. The portfolio spans efficacy and safety testing, analytical chemistry and bioanalysis, clinical imaging, clinical trial support, and specialized dermatology, immunology, oncology, and neurobiology models. Service delivery is anchored by the Münster, Germany facility and is complemented by additional R&D sites within the QIMA Life Sciences network.
Is Monasterium Laboratory a public or private company?
Monasterium Laboratory is a private company. It is classified as unknown and is currently operating.
When was Monasterium Laboratory founded?
Monasterium Laboratory was founded in 2015. It employs 11 to 50 people.
Where is Monasterium Laboratory based?
Monasterium Laboratory is headquartered in Münster, Germany, in the Europe region.
How does Monasterium Laboratory make money?
One revenue line is on record: contract Research Services.
Who are Monasterium Laboratory's main competitors?
Direct peers on record are SGS SA, Eurofins Scientific, Inotiv and Intertek Group. Emerging players are Sinclair Pharma, Bionova Scientific and Crown Bioscience. Broad incumbents are IQVIA, ICON plc and Charles River Laboratories.
Does Monasterium Laboratory have an API?
No public API is recorded for Monasterium Laboratory.
What industry is Monasterium Laboratory in?
Monasterium Laboratory's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 5417 and its SIC code is 8734.